GSK (GSK): news on Saturday 17 October 2026

The 10 stories

Each headline's own score, strongest first. Links go to the publisher.

• −9.2 Strikes at GSK’s Belgian sites over plans to cut 1200 jobs Chemistry World
  Strikes at Belgian sites over 1,200 planned job cuts.
• +7.5 GSK showcases pipeline momentum across lung, gynaecological and gastrointestinal cancers at ESMO 2026 GSK
  Oncology pipeline progress showcased at major cancer conference.
• +6.7 FTSE 100 GSK (LSE:GSK): Strong Quarter Signals for Dividend Kalkine Media
  Strong quarter supports dividend outlook.
• +5.8 GSK (NYSE: GSK) Share Price Rises After CEO And CFO Boost Personal Holdings As Technical Pressure Persists Foreign Policy Journal
  CEO and CFO buying shares signals insider confidence; share price up.
• +4.2 GSK Enlists Viola Davis in National Shingles Awareness Campaign MyChesCo
  Shingles vaccine awareness campaign supports product marketing.
• −3.3 Weekly Buzz: RHHBY, TEVA Win FDA Nod; MLAB, GSK Cut Jobs; AZN, VIR Deals; KRYS, ABBV Report Data RTTNews
  GSK job cuts mentioned in weekly roundup among many firms.
• +3.3 GSK stock: RBC maintains GBp 1,975 target for GSK stock - ad-hoc-news.de ad-hoc-news.de
  RBC maintains price target, mildly supportive.
• −1.7 GSK shares technical analysis: Overbought conditions highlight reversal setup Traders Union
  Technical analysis flags overbought conditions and possible reversal.
• +0.8 GSK plans USD 800 million rebuild. GSK stock falls 1.04 percent - ad-hoc-news.de ad-hoc-news.de
  USD 800 million rebuild plan offset by small share fall.
• 0.0 UBS Keeps Their Hold Rating on GlaxoSmithKline (GSK) The Globe and Mail
  UBS keeps neutral Hold rating.